Logo image of XHR

XENIA HOTELS & RESORTS INC (XHR) Stock Fundamental Analysis

NYSE:XHR - New York Stock Exchange, Inc. - US9840171030 - REIT - Currency: USD

13.3  +0.01 (+0.08%)

Fundamental Rating

5

Taking everything into account, XHR scores 5 out of 10 in our fundamental rating. XHR was compared to 129 industry peers in the Diversified REITs industry. Both the profitability and the financial health of XHR get a neutral evaluation. Nothing too spectacular is happening here. XHR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

XHR had positive earnings in the past year.
In the past year XHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: XHR reported negative net income in multiple years.
XHR had a positive operating cash flow in 4 of the past 5 years.
XHR Yearly Net Income VS EBIT VS OCF VS FCFXHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

XHR's Return On Assets of 2.17% is fine compared to the rest of the industry. XHR outperforms 67.44% of its industry peers.
XHR has a better Return On Equity (5.14%) than 65.89% of its industry peers.
XHR's Return On Invested Capital of 2.99% is in line compared to the rest of the industry. XHR outperforms 58.91% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for XHR is in line with the industry average of 3.07%.
The 3 year average ROIC (2.74%) for XHR is below the current ROIC(2.99%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.17%
ROE 5.14%
ROIC 2.99%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
XHR Yearly ROA, ROE, ROICXHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

XHR's Profit Margin of 5.81% is in line compared to the rest of the industry. XHR outperforms 52.71% of its industry peers.
XHR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.66%, XHR is doing worse than 79.84% of the companies in the same industry.
XHR's Operating Margin has declined in the last couple of years.
XHR has a Gross Margin of 54.73%. This is in the lower half of the industry: XHR underperforms 74.42% of its industry peers.
In the last couple of years the Gross Margin of XHR has remained more or less at the same level.
Industry RankSector Rank
OM 9.66%
PM (TTM) 5.81%
GM 54.73%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
XHR Yearly Profit, Operating, Gross MarginsXHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

5

2. Health

2.1 Basic Checks

XHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, XHR has less shares outstanding
The number of shares outstanding for XHR has been reduced compared to 5 years ago.
Compared to 1 year ago, XHR has an improved debt to assets ratio.
XHR Yearly Shares OutstandingXHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
XHR Yearly Total Debt VS Total AssetsXHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.69, we must say that XHR is in the distress zone and has some risk of bankruptcy.
With a decent Altman-Z score value of 0.69, XHR is doing good in the industry, outperforming 63.57% of the companies in the same industry.
XHR has a debt to FCF ratio of 56.29. This is a negative value and a sign of low solvency as XHR would need 56.29 years to pay back of all of its debts.
XHR has a Debt to FCF ratio of 56.29. This is in the better half of the industry: XHR outperforms 61.24% of its industry peers.
XHR has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
XHR has a Debt to Equity ratio of 1.17. This is comparable to the rest of the industry: XHR outperforms 52.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 56.29
Altman-Z 0.69
ROIC/WACC0.4
WACC7.51%
XHR Yearly LT Debt VS Equity VS FCFXHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.64 indicates that XHR should not have too much problems paying its short term obligations.
XHR has a better Current ratio (1.64) than 68.99% of its industry peers.
XHR has a Quick Ratio of 1.64. This is a normal value and indicates that XHR is financially healthy and should not expect problems in meeting its short term obligations.
XHR's Quick ratio of 1.64 is fine compared to the rest of the industry. XHR outperforms 68.99% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
XHR Yearly Current Assets VS Current LiabilitesXHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

XHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 186.36%, which is quite impressive.
The earnings per share for XHR have been decreasing by -23.70% on average. This is quite bad
XHR shows a small growth in Revenue. In the last year, the Revenue has grown by 4.81%.
XHR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.99% yearly.
EPS 1Y (TTM)186.36%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%273.33%
Revenue 1Y (TTM)4.81%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%5.38%

3.2 Future

Based on estimates for the next years, XHR will show a very strong growth in Earnings Per Share. The EPS will grow by 42.53% on average per year.
XHR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.17% yearly.
EPS Next Y243.4%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue Next Year2.57%
Revenue Next 2Y2.96%
Revenue Next 3Y3.17%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XHR Yearly Revenue VS EstimatesXHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
XHR Yearly EPS VS EstimatesXHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2 -3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.11 indicates a rather expensive valuation of XHR.
Based on the Price/Earnings ratio, XHR is valued cheaply inside the industry as 83.72% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.86. XHR is valued slightly cheaper when compared to this.
XHR is valuated quite expensively with a Price/Forward Earnings ratio of 47.37.
Compared to the rest of the industry, the Price/Forward Earnings ratio of XHR is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of XHR to the average of the S&P500 Index (34.94), we can say XHR is valued slightly more expensively.
Industry RankSector Rank
PE 21.11
Fwd PE 47.37
XHR Price Earnings VS Forward Price EarningsXHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XHR is valued a bit cheaper than 79.07% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, XHR is valued a bit cheaper than 62.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 51.9
EV/EBITDA 10.92
XHR Per share dataXHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XHR's earnings are expected to grow with 42.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y36.82%
EPS Next 3Y42.53%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.09%, XHR is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.54, XHR is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.36, XHR pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.09%

5.2 History

The dividend of XHR decreases each year by -15.89%.
XHR has paid a dividend for at least 10 years, which is a reliable track record.
XHR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-15.89%
Div Incr Years2
Div Non Decr Years2
XHR Yearly Dividends per shareXHR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

XHR pays out 40.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP40.97%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
XHR Yearly Income VS Free CF VS DividendXHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M
XHR Dividend Payout.XHR Dividend Payout, showing the Payout Ratio.XHR Dividend Payout.PayoutRetained Earnings

XENIA HOTELS & RESORTS INC

NYSE:XHR (8/21/2025, 10:02:00 AM)

13.3

+0.01 (+0.08%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners98.26%
Inst Owner Change-1.65%
Ins Owners0.94%
Ins Owner Change0%
Market Cap1.31B
Analysts78
Price Target14.48 (8.87%)
Short Float %3.91%
Short Ratio3.32
Dividend
Industry RankSector Rank
Dividend Yield 4.09%
Yearly Dividend0.47
Dividend Growth(5Y)-15.89%
DP40.97%
Div Incr Years2
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.14)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.72%
Min EPS beat(2)81.79%
Max EPS beat(2)163.65%
EPS beat(4)3
Avg EPS beat(4)13.88%
Min EPS beat(4)-199.01%
Max EPS beat(4)163.65%
EPS beat(8)6
Avg EPS beat(8)71.52%
EPS beat(12)7
Avg EPS beat(12)103.41%
EPS beat(16)10
Avg EPS beat(16)88.82%
Revenue beat(2)2
Avg Revenue beat(2)4.02%
Min Revenue beat(2)3.88%
Max Revenue beat(2)4.16%
Revenue beat(4)2
Avg Revenue beat(4)1.12%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)4.16%
Revenue beat(8)3
Avg Revenue beat(8)0.33%
Revenue beat(12)5
Avg Revenue beat(12)0.23%
Revenue beat(16)9
Avg Revenue beat(16)1.91%
PT rev (1m)2.9%
PT rev (3m)12.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-247.14%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-3.85%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE 21.11
Fwd PE 47.37
P/S 1.22
P/FCF 51.9
P/OCF 7.59
P/B 1.08
P/tB 1.08
EV/EBITDA 10.92
EPS(TTM)0.63
EY4.74%
EPS(NY)0.28
Fwd EY2.11%
FCF(TTM)0.26
FCFY1.93%
OCF(TTM)1.75
OCFY13.17%
SpS10.89
BVpS12.32
TBVpS12.27
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.17%
ROE 5.14%
ROCE 3.78%
ROIC 2.99%
ROICexc 3.19%
ROICexgc 3.24%
OM 9.66%
PM (TTM) 5.81%
GM 54.73%
FCFM 2.35%
ROA(3y)1.01%
ROA(5y)-1.39%
ROE(3y)2.2%
ROE(5y)-2.79%
ROIC(3y)2.74%
ROIC(5y)N/A
ROICexc(3y)2.94%
ROICexc(5y)N/A
ROICexgc(3y)2.99%
ROICexgc(5y)N/A
ROCE(3y)3.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.42%
ROICexc growth 3YN/A
ROICexc growth 5Y-6.41%
OM growth 3YN/A
OM growth 5Y-7.09%
PM growth 3YN/A
PM growth 5Y-20.5%
GM growth 3Y-0.24%
GM growth 5Y-0.93%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 56.29
Debt/EBITDA 6.06
Cap/Depr 112.83%
Cap/Sales 13.73%
Interest Coverage 1.19
Cash Conversion 73.66%
Profit Quality 40.49%
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z 0.69
F-Score8
WACC7.51%
ROIC/WACC0.4
Cap/Depr(3y)167.19%
Cap/Depr(5y)114.68%
Cap/Sales(3y)21.77%
Cap/Sales(5y)17.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)186.36%
EPS 3YN/A
EPS 5Y-23.7%
EPS Q2Q%273.33%
EPS Next Y243.4%
EPS Next 2Y36.82%
EPS Next 3Y42.53%
EPS Next 5YN/A
Revenue 1Y (TTM)4.81%
Revenue growth 3Y19.02%
Revenue growth 5Y-1.99%
Sales Q2Q%5.38%
Revenue Next Year2.57%
Revenue Next 2Y2.96%
Revenue Next 3Y3.17%
Revenue Next 5YN/A
EBIT growth 1Y20.56%
EBIT growth 3YN/A
EBIT growth 5Y-8.94%
EBIT Next Year195.4%
EBIT Next 3Y48.07%
EBIT Next 5YN/A
FCF growth 1Y-76.27%
FCF growth 3Y37.05%
FCF growth 5YN/A
OCF growth 1Y-8.64%
OCF growth 3Y58.91%
OCF growth 5Y-7.87%